Supernus Pharmaceuticals Inc.
SUPN | NASDAQ
$42.78
+$0.78 (+1.86%)
At close: Sep 21, 2026, 4:00 PM ET
$42.78
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -73.09 | 26.99 | 1.2K | 31.57 | 28.87 | 10.44 |
PEG Ratio | 0.48 | 0 | -12.27 | 2.66 | -0.50 | 0.90 |
PS Ratio | 3.90 | 3.01 | 2.60 | 2.87 | 2.67 | 2.54 |
PB Ratio | 2.64 | 1.92 | 1.71 | 2.16 | 1.90 | 1.78 |
P/FCF Ratio | 61 | 11.64 | 14.28 | 16.44 | 12.38 | 9.81 |
P/OCF Ratio | 59.28 | 11.59 | 14.21 | 16.39 | 12.18 | 9.57 |
OCF/S Ratio | 6.58 | 25.98 | 18.29 | 17.51 | 21.93 | 26.59 |
Debt / Equity Ratio | 0.04 | 0.03 | 0.05 | 0.50 | 0.52 | 0.56 |
Quick Ratio | 1.66 | 2.16 | 1.43 | 0.93 | 1.63 | 2.37 |
Current Ratio | 1.90 | 2.35 | 1.70 | 1.07 | 1.91 | 2.57 |
Asset Turnover | 0.49 | 0.48 | 0.48 | 0.39 | 0.34 | 0.35 |
Interest Coverage | n/a | n/a | -2.18 | 6.52 | 3.67 | 7.31 |
Return on Equity | -3.63% | 7.13% | 0.14% | 6.85% | 6.55% | 17.04% |
Return on Assets | -2.65% | 5.40% | 0.10% | 3.57% | 3.16% | 8.44% |
Return on Invested Capital | -2.58% | 5.69% | -0.25% | 3.24% | 4.55% | 10.35% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 89.63% | 88.23% | 86.21% | 86.93% | 87.05% | 89.92% |
Net Profit Margin | -5.36% | 11.16% | 0.22% | 9.10% | 9.21% | 24.39% |
Pretax Profit Margin | -6.82% | 14.79% | 0.46% | 9.10% | 12.62% | 32.41% |
Operating Profit Margin | -5.13% | 12.34% | -0.87% | 6.91% | 14.84% | 33.38% |
FCF Margin | 6.40% | 25.87% | 18.19% | 17.45% | 21.57% | 25.93% |
EBITDA Margin | 5.92% | 26.94% | 14.82% | 22.98% | 22.28% | 40.46% |
Add to Watchlist
Select watchlists to add or remove SUPN